Drug Trial Radar · NCT06555263
Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer
Last checked: Nov 19, 2026Latest source record: Aug 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Aug 21, 2024
Primary completion
May 1, 2025
Study completion May 1, 2025
Sponsor
- Lead sponsor
- Sutro Biopharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2 study evaluating STRO-002 in subjects with previously treated advanced or metastatic non-small cell lung cancer expressing FOLR1
Conditions
- Lung Cancer
- Lung Cancer Metastatic
- Lung Cancer, Nonsmall Cell
- Lung Cancer Non-Small Cell Stage IIIB
- Lung Cancer Non-small Cell Stage IV
- Lung Cancer, Non-small Cell
Interventions
Luveltamab tazevibulinDrug
Luveltamab tazevibulin is an antibody-drug conjugate (ADC) targeting folate receptor α (FRα or FOLR1). It consists of an IgG1 antibody (SP8166) conjugated to cathepsin cleavable 3-aminophenyl hemiasterlin payload, yielding a homogenous ADC with a drug antibody ratio of four. The active warhead (SC209) inhibits tubulin polymerization leading to mitotic arrest and cell death.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR)Time frame: up to 24 months
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
UC San Diego Health - Moores Cancer Center
La Jolla, California
Georgetown University Medical Center - Lombardi Comprehensive Cancer Center
Washington D.C., District of Columbia
Florida Cancer Specialists & Research Institute (FCS)
Lake Mary, Florida
Tampa General Hospital - Cancer Center of South Florida
Tampa, Florida
HealthPartners Frauenshuh Cancer Center
Saint Louis Park, Minnesota
HealthPartners Cancer Center at Regions Hospital
Saint Paul, Minnesota
Mary Crowley Cancer Research
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.